Risk of malignancy and the use of disease-modifying therapy in multiple sclerosis: exploring the role of DMT in a multi-center study by Mohammed Bayounis, Mohammed Bayounis, Mohammed Bin Mahfooz, Mohammed Bin Mahfooz, Mohammed Assiri, Mohammed Assiri, Yousef Alghamdi, Yousef Alghamdi, Fahad Alturki, Fahad Alturki, Mahdi Almutairi, Mahdi Almutairi, Abdullah Alshelawy, Abdullah Alshelawy, Mohammed Alosaimi, Mohammed Alosaimi, Faisal Almutawa, Faisal Almutawa, Abdulrahman Alammar, Abdulrahman Alammar, Yahya Alyahya, Yahya Alyahya, Osama Khojah, Osama Khojah, Osama Khojah, Seraj Makkawi, Seraj Makkawi, Seraj Makkawi, Yaser Al Malik, Yaser Al Malik, Yaser Al Malik

Get full text